T57.2X
Toxic effect of manganese and its compounds
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T57.2X refers to the toxic effect of manganese and its compounds. Manganese is a mineral naturally found in the environment and used in various industrial processes. While manganese is essential for human health in small amounts, excessive exposure can lead to toxicity, affecting multiple organ systems. This condition is recognized medically as manganese poisoning or manganese toxicity. It can occur through inhalation, ingestion, or skin contact, especially in occupational settings or areas with environmental contamination. Recognizing the symptoms and understanding causes are vital for prevention and management of manganese toxicity.
Causes & Symptoms
Clinical Causes: Occupational exposure in industries such as welding, mining, or manufacturing involving manganese compounds Inhalation of manganese dust or fumes in workplaces without proper safety measures Ingestion of contaminated water or food containing elevated manganese levels Environmental accidents leading to release of manganese compounds into air, water, or soil Long-term use of manganese-containing supplements or medications in excessive doses
Key Symptoms: Neurological symptoms such as tremors, rigidity, and bradykinesia resembling Parkinson's disease Muscle weakness and coordination problems Psychological changes including mood swings, irritability, or behavioral disturbances Cognitive impairments such as memory issues or difficulty concentrating Respiratory symptoms if inhaled manganese fumes irritate the airways Gastrointestinal issues like nausea or abdominal discomfort in cases of ingestion
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of exposure history, clinical examination, and laboratory tests. Blood, urine, or hair analysis can provide evidence of elevated manganese levels. Imaging studies like MRI may reveal specific patterns in the brain associated with manganese accumulation, especially in the basal ganglia. Healthcare practitioners might also assess neurological and psychological symptoms to differentiate manganese toxicity from other neurological disorders.
Treatment Protocols: Management involves eliminating or reducing exposure to manganese sources. Chelation therapy, using agents that bind manganese for removal from the body, may be employed in severe cases. Supportive treatments include neurological rehabilitation, symptom management, and monitoring of organ functions. Prevention strategies emphasize adequate workplace safety measures, use of protective equipment, and environmental controls to limit manganese exposure.
Clinical Advice & FAQs
Billing Guidance
Is T57.2X a billable ICD-10 code?
Yes, T57.2X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T57.2X?
Clinical documentation must specify the nature of Toxic effect of manganese and its compounds and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
